INVITED PRESENTATIONS JULY 1, 2010 – JUNE 30, 2011
Michelle Alfa
“Flexible Endoscopes: The “A,B,C’s” of Monitoring Manual Cleaning Efficacy!”. Presented at The Food and Drug
Administration Reprocessing of Reusable Medical Devices Workshop. Silver Spring, Maryland. June 8-9, 2011.
“How Clean is “Clean Enough” when Reprocessing Surgical Instruments?” Presented at The Food and Drug
Administration Reprocessing of Reusable Medical Devices Workshop. Silver Spring, Maryland. June 8-9, 2011.
“Medical Device Reprocessing: 911 call” Presented at the Johnson & Johnson Reprocessing – from the Basement
to the Boardroom symposium. Toronto, ON. June 4, 2011.
“Optimisation of follow-up samples for patients with pulmonary tuberculosis” Presented at 21 st European
Congress of Clinical Microbiology and Infectious Disease and the 27 th International Congress of Chemotherapy.
Milan, Italy. May 7-10, 2011.
“Cleaning and Disinfection Practices” Presented at the Provincial Infection Control Network of British Columbia
conference. Richmond, BC. April 7-8, 2011.
“TB Diagnostics and Follow-up” Presented at the WRHA Regional Tuberculosis Workshop. Winnipeg, Manitoba.
March 24, 2011.
“Clostridium difficile: The Sinister Spore Saga” Webber Teleconference, December 16, 2010.
“Clostridium difficile: What to do to contain the Poo!” Clostridium difficile Symposium, Winnipeg, MB, December
7, 2010.
“Advancements in Endoscope Reprocessing: Lowering Risk of Infection Transmission”. Johnson and Johnson
Webinar, November 15, 2010.
“Reprocessing of Implants: What are the Issues?” Presented at the 11th World Sterilization Congress & 7th Int’l
Symposium of Sterilization & Hospital Infection Control. Sau Paulo, Brazil. July 30 – August 1, 2010.
“Monitoring Flexible Endoscope Channels to Assure Cleaning” Presented at the 11th World Sterilization Congress
& 7th Int’l Symposium of Sterilization & Hospital Infection Control. Sau Paulo, Brazil. July 30 – August 1, 2010.
“Enzymatic Detergent: role in cleaning of Medical Instruments” Presented at the 11th World Sterilization Congress
& 7th Int’l Symposium of Sterilization & Hospital Infection Control. Sau Paulo, Brazil. July 30 – August 1, 2010.
Fred Aoki
Antiviral Drugs for the Prevention & Treatment of Illness due to Seasonal and Pandemic Influenza Viruses.
Toronto Invasive Bacterial Diseases Network Education Day. Toronto, Ontario.
Harvey Artsob
Studying zoonotic diseases: past and present approaches. Keynote banquet speaker. International Conference on
Diseases in Nature Communicable to Man. August 8-10, Fairbanks, Alaska, 2010.
Arboviruses relevant to the northern ecology. Zoonotic and Parasitic Infections in Alaska (Z-PAK): Climate change
and the potential impact on disease distribution and prevalence. August 11-12, Fairbanks, Alaska, 2010.
Factors influencing disease emergence. Annual International Symposium Biosecurity and Biosafety: Future trends
and solutions. October 13-15, Milan, Italy, 2010.
Addressing emerging diseases of animal origin. D.L.T. Smith Lecture. Western College of Veterinary Medicine.
February 8, Saskatoon, Saskatchewan, 2011.
Addressing emerging disease issues: experiences of a zoonotic diseases scientist. Keynote speaker for 50 th Gala
celebration of the School of Occupational & Public Health. Reyerson University. March 26, Toronto, Ontario. 2011.
Blake Ball
Comparative proteomic analysis of mucosal samples from the female genital tract Invited Talk: HIV Mucosal
Immunology Group Meeting, Apr 12, 2011, Seattle Washington.
Recent activities of the National Laboratory for HIV Immunology Invited Talk: International HIV Prevention
Exchange Symposium Saturday, January 29, 2011, Winnipeg, Manitoba.
Correlates of protection against HIV infection: Studies of HIV Exposed, Seronegative subjects (HESN) Invited Talk
University of Nairobi Annual Review meeting 2011, Jan 17-21, 2011, Nairobi, Kenya.
QASI: An International External Quality Assessment (EQA) Program Invited Talk: University of Nairobi Annual
Review meeting 2011, Jan 17-21, 2011, Nairobi, Kenya.
Proteomic analysis of different “compartments” in the female genital tract Invited Talk: HIV Mucosal
Immunology Group meeting June 25, 2010 Los Angeles California.
Coordinating Medical Research and Education in Times of Crisis Invited Talk: East-West Alliance 2010 Conference,
Winnipeg, Manitoba, June 3, 2010.
Kathryn Bernard
Updated look at Corynebacterium species and other medically-relevant, fastidious or good-growing Gram positive
Rods, an all day workshop for the South Western Association of Clinical Microbiology (‘SWACM’) held May 21,
2010 in Arlington TX. Part One: Overview and Corynebacterium species; Part Two: Coryneforms and other
Gram Positive Rods.
16S rRNA gene Sequencing. The Good, the Bad and the Ugly. A presentation to the National Molecular Group
(NMG) October 19 2010, St, Joseph’s Hospital, Hamilton On.
An overview of the Canadian National Microbiology Laboratory and Special Bacteriology Section. October 27,
2010 at the State Research Institute, Obolensk, Russia.
A Review of Medically Relevant Corynebacterium species and other ‘Coryneforms’. November 16, 2010 for the
Teleconference Network of Texas, San Antonio TX.
A Review of Medically Relevant Corynebacterium species and other ‘Coryneforms’. January 31, 2011, Health
Protection Agency, Colindale UK.
A Review of Genera Leptotrichia and Sneathia: Evidence of Additional Heterogenity. Delivered as part of the
ICSP –Gram Negative Anaerobes subcommittee meeting, Feb 2, 2011 at the Health Protection Agency, Colindale
UK.
James Blanchard
September, 2010: “Programs and Science: Seeking the Academic Mission in Global Health”. Consortium of
Universities for Global Health Annual Meeting. University of Washington, Seattle, USA.
Timothy Booth
On-camera interview and appearance for the show Finding Stuff Out, a science-based kids TV show being
produced for TVO, Monday, June 13th, 2011.
On-camera appearance for the Discovery Channel Canada, “Daily Planet” science programme segment
highlighting the capabilities of the NML when an unknown pathogen appears in Canada, Monday, January 24th
2011: http://watch.discoverychannel.ca/daily-planet/march-2010/daily-planet---march-11-2010/#clip406907
(starts at about the 7:45 minute mark).
Eric Bow
October 20, 2010
Palliative Care Education Series, Winnipeg, MB
Presentation: "Approach to the management of infections in patients with terminal
cancer. Be mindful of the goals of treatment."
October 21, 2010
Department of Pediatrics Grand Rounds, University of Manitoba
Presentation: “Fungal Therapy in Immunocompromised Hosts”
November 9, 2010
Saskatoon Haematology/Oncology and ID Physician Group, Saskatoon, SK
“Managing Fungal Infections in the HSCT Patient”
December 4, 2010
ASH Symposium with Japanese Haematologists, Orlando, Florida
“Pre-emption vs Prevention vs Empiricism vs Directed Therapy”
January 31, 2011
Canadian Association of Nurses in Oncology (CANO) Manitoba Chapter Winnipeg MB
"Approach to the management of infections in patients with terminal cancer. Be mindful
of the goals of treatment."
May 28, 2011
2nd PRIME Summit: Pfizer Regional Anti-Infectives Meeting for Excellence
Kunming, China
“IFI in leukemic and BMT Patients: Recent guidelines and clinical relevance”
June 1, 2011
Special BMT Rounds: Princess Margaret Hospital, Toronto, ON
“Management of Fungal Infections in the HSCT Patient: Complex Cases”
June 2, 2011
Hematology Lecture Series, Vancouver General Hospital, Vancouver, BC
“Of Conidia & Nodularities … High-Risk Patient-Centred Stuff We Should Think About”
June 8, 2011
Symposium: Mucosal barrier injury, innate immunity and infection
Radboud University, Nijmegen, The Netherlands
“Consequences and infectious complications”
June 25, 2011
Infectious Disease Conference 2011, Hong Kong
Co-organized by the Hospital Authority Infectious Disease Centre, Hong Kong,
Department of Medicine & Geriatrics, Princess Margaret Hospital and
The Hong Kong Society for Infectious Diseases
Presentations: “Management of Neutropenic Fever” and
“Fungal infection in immunocompromised patients”
Jared Bullard
What We Should Know About Pneumococcal Disease in Kids. Invited speaker to the Canadian Respiratory
Conference in Niagra Falls, Ontario (May 2011).
A Case of HIV MTCT in Manitoba in 2010 and Review of Epidemiological and Clinical Characteristics of Maternal
and Pediatric HIV in Manitoba, Canada from 1989 to 2010.
Invited speaker to the Manitoba HIV Program’s CME Guest Lecture Series, Winnipeg, Manitoba (April 2011)
HIV Testing: An Update for 2010.
Invited presenter to the Department of Pediatrics Small Group Discussion (September 2010).
David Butler-Jones
2010-07-17: AIDS 2010 Conference - Indigenous Peoples Satellite, Vienna Austria
2010-08-22: IPAC Conference - session on Pandemic Planning, Toronto, ON
2010-08-25: Canada 55+ Games, Brockville, ON
2010-08-30: Remarks to Staff - Winnipeg Town Hall, Winnipeg MB
2010-08-31: Speech to Kiwanis Golden K, Barrie, ON
2010-09-01: Federation of Canadian Municipalities, Iqaluit, NU
2010-09-01: Remarks to National Collaborating Centre for Aboriginal Health Advisory Committee, Iqaluit, NU
2010-09-14: Remarks to Infectious Disease Prevention and Control Branch Staff Retreat , Ottawa, ON
2010-09-15: Agricultural Biotechnology Conference International Conference , Saskatoon, SK
2010-09-26: International Society of Hypertension - presentation on Cardiovascular Health, Vancouver, BC
2010-09-26: International Society of Hypertension Conference - opening remarks, Vancouver, BC
2010-09-29: Appearance Before the Senate Social Affairs Committee on Pandemic Preparedness, Ottawa, ON
2010-09-29: Remarks for a visit by the Canada School of Public Service - Leadership Across Borders Program,
Ottawa, ON
2010-10-06: Appearance Before the Senate Social Affairs Committee on Pandemic Preparedness re: vaccines,
Ottawa, ON
2010-10-14: Remarks for an Assistant Deputy Minister Forum, Gatineau, QC
2010-10-14: Keynote Address at the Canadian Public Health Association Biennial Meeting - Fredericton, NB
2010-10-21: Presentation at the Gairdner International Vaccine Symposium, Saskatoon, SK
2010-10-26: Presentation at ‘Championing Public Health Nutrition’: A Dialogue with the Canadian Centre for
Science in the Public Interest, Ottawa, ON
2010-10-27: Keynote Address to the Aboriginal Nurses Association of Canada Conference, Toronto, ON
2010-11-04: Opening remarks at a Workshop on Hepatitis C, Ottawa, ON
2010-11-04: Appearance before the Standing Committee on progress on Weatherill recommendations , HESA,
Ottawa, ON
2010-11-21: Presentation on the CPHO’s 2010 report, Journées Annuelles de la Sante Publique, Québec City, QC
2010-11-25: Appearance before the Standing Committee on Supplementary Estimates 'B', HESA, Ottawa, ON
2010-11-29: Remarks for the 2nd Task Force Meeting on Prevention, Ottawa, ON
2010-12-01: Remarks at the Deputy Minister’s Breakfast on the CPHO’s 2010 Report , Ottawa, ON
2010-12-01: Remarks to National Microbiology Staff on World AIDS Day (teleconference)
2010-12-04: Speech to the Canadian Association on Gerontology's 39th Annual Scientific and Educational
Meeting, Montreal, QC
2010-12-06: Remarks at the Canadian Immunization Conference , Quebec City, QC
2010-12-07: Panel Discussion at the Global Health Symposium, Ottawa, ON
2010-12-10: Remarks for an Institute of Population and Public Health Intervention Research Symposium ,
Toronto, ON
2010-12-10: Remarks for a PHAC Executive Committee Retreat , Ottawa, ON
2011-01-05: Welcoming Remarks for the Canadian Public Health Association Centenary Exhibit , Ottawa, ON
2011-01-06: Guest Lecture at the University of Manitoba’s H1N1 Seminar , Winnipeg, MB
2011-01-10: Keynote Remarks at the Insight Conference on Chronic and Complex Health Care , Halifax, NS
2011-01-24: Remarks (x3) for a PHAC Town Hall, Ottawa, ON
2011-02-09: Welcoming Remarks for an International Influenza Seroprevalence Meeting, Ottawa, ON
2011-02-14: Presentation - Breaking Down Barriers, Creating Connections - One Health Australia, Melbourne
2011-02-16: Presentation - Science, Policy and Political Action - One Health Australia, Melbourne
2011-02-21: Presentation to the Public Health Association of Australia , Canberra
2011-03-10: Appearance Before the Standing Committee on Supplementary Estimates "C" – HESA, Ottawa, ON
2011-03-11: Guest Lecture at the University of Manitoba’s 17th Annual Research Forum - Aging and Seniors,
Winnipeg, MB
2011-03-22: Remarks for the Childhood Obesity Engagement Strategy - Preventing Childhood Obesity - Moving
Policy Recommendations to Action, Ottawa, ON
2011-03-24: Welcoming Remarks to the FASDONE Provincial Conference, Toronto, ON
2011-03-25: Remarks for a BC Town Hall for PHAC staff, Vancouver, BC
2011-03-25: Remarks for a Multiple Sclerosis Announcement with the Minister of Health, Ottawa, ON
2011-03-26: Metropolis Conference - Plenary presentation on Immigration, Diversity and Public Health,
Vancouver, BC
2011-03-28: Welcoming Remarks at the National Aboriginal Council on HIV/AIDS, Ottawa, ON
2011-03-29: Remarks at the PHAC Science and Research Forum , Gatineau, QC
2011-04-06: Welcoming remarks at the Ontario Public Health Convention, Toronto, ON
2011-05-12: Remarks at the World Health Assembly 2011, Geneva, Switzerland
2011-05-26: Presentation to the Heads of Federal Agencies Learning Day, Ottawa, ON
2011-06-02: Presentation to Canadian Hospital Acquired Infections Association Canada, Toronto, ON
2011-06-06: Welcoming remarks at the Field Services Training Institute, Vancouver, BC
Jingxin Cao
Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas, USA, April 25 2011,
Application of vaccinia E3L deletion mutant based system for study of viral dsRNA `binding proteins: Inhibition of
cytokine induction and interferon antiviral state.
Department of Applied Chemistry, National Chia-Yi University, Taiwan, May 30 2011, Dual activities of vaccinia E3
protein: inhibition of cytokine expression and IFN-indcued antiviral activities.
Institute of Chemistry, Academia Sinica, Taipei, Taiwan, May 31 2011, Identification of vaccinia RNA species as
PAMPs and mutagenesis studies of vaccinia E3 protein for its role in interfering with vaccinia PAMP-induced
antiviral activities.
Kevin Coomba
2010. Proteomics of influenza virus-infected human cells. Pandemic Preparedness Strategic Research Initiative;
Outcomes, Impacts and Lessons Learned, Montreal, November 12.
2010. Measuring global host protein responses to virus infections. Keynote Address. International Conference of
Communicable Diseases Surveillance and Prospects of Laboratory Testing, Bitumi, Republic of Georgia, November
22.
Michael Drebot
Invited Speaker and Session Expert, Drebot MA: American Association of Tissue Banks Consultation Workshop.
“West Nile virus: Scientific considerations for tissue donors”. April 23, 2010. Washington DC.
Invited Speaker, Drebot MA. Emerging Infectious Disease. Biophotonics Workshop. Quebec City, Quebec.
September 22-23, 2010.
Invited speaker and Session Expert / Consultant, Drebot MA: Grand Challenges of Canada - Diagnostic
Development Initiatives for 3rd World Countries. Toronto, Ontario, September 29, 2010.
Invited Speaker, Drebot M. Diagnostic considerations for emerging zoonotic disease. Zoonotic Diseases
Symposium, Annual Review Meeting of the University of Nairobi STD/AIDS Collaborative Group. Nairobi, Kenya.
January 26-29, 2011.
Invited Speaker, Drebot MA. An Overview of California Serogroup Virus Diagnostics and Surveillance in Canada in
2010. National Meeting on West Nile virus and Other Non-Enteric Zoonotic Diseases, Jan 21-22, Ottawa,
Ontario, 2011.
John Embil
A View from the Trenches: Case Histories in Infectious Diseases. Primary Care Update, Winnipeg Convention
Centre, October 1, 2010.
Medical Grand Rounds: Infection Control: Never a Dull Moment! University of Manitoba, October 19, 2010.
Ophthalmology Grand Rounds: Infectious Diseases Potpourri. Misericordia Health Centre, Winnipeg, Manitoba,
November 3, 2010.
Report from the Vancomycin Resistant Enterococcus Working Group. Canadian Nosocomial Infections
Surveillance Programs/Canadian Hospital Epidemiology Committee Annual General Meeting, Ottawa, Ontario,
November 15, 2010.
The Good, The Bad, The Ugly: The Diabetic Foot and the Future of Pedorthics. Key Note Presentation at 2010
North American Pedorthic Congress, Orlando, Florida, November 20, 2010
Wound Care: Science or Witchcraft. 2010 North American Pedorthic Congress, Orlando, Florida, November 20,
2010.
Infection Control and C. difficile. Clostridium difficile Associated Disease – CDAD Symposium. University of
Manitoba, December 7, 2010.
Hand Hygiene – Our Dirty Little Secret. Winnipeg Regional Health Authority Critical Care Quality Symposium
2011. March 3, 2011.
A Bone to PICC: Intravenous versus Oral Therapy for the Management of Diabetic Foot Osteomyelitis DF Con
2011: Diabetic Foot Global Conference, Los Angeles, California, March 25, 2011.
Healing Resource Wounds through the Use of Evidence: The Silver Lining in a Vacuum of Evidence. 2011
Canadian Agency for Drugs and Technologies in Health (CADTH) Symposium, Vancouver, British Columbia, April
3-5, 2011.
Panel Discussion: Health Technology Assessments for Health System Sustainability: Opportunities and
Challenges. 2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Symposium, Vancouver,
British Columbia, April 3-5, 2011.
Science versus Witchcraft in the Management of the Diabetic Foot. Winnipeg Vascular and Endovascular
Symposium, Winnipeg, Manitoba, April 7, 2011.
What to do with What Lurks Beneath the Dressing: Managing the Diabetic Foot. First Nations and Inuit Branch
– Health Canada. Winnipeg, Manitoba, April 14, 2011.
Antibiotics and Clinical Practice. First Nations and Inuit Branch – Health Canada. April 14, 2011, Winnipeg,
Manitoba.
Chronic Disease Management Symposium: The VIPS of Diabetic Foot Care. Winnipeg, Manitoba, May 7, 2011.
Infection Prevention and Control in Action. Canadian Orthopedic Nurses Association – Annual General Meeting.
Winnipeg, Manitoba, June 8, 2011.
Joanne Embree
HIV/AIDS. 4th International Meeting on Indigenous Child Health: Securing our Future: Advancing Circles of Caring.
Vancouver, BC, March 4-6, 2011.
H1N1: An international perspective – Canadian Experience. 4th International Meeting on Indigenous Child Health:
Securing our Future: Advancing Circles of Caring. Vancouver, BC, March 4-6, 2011.
HIV in Canada: Implications for Women’s and Children’s Health. Women’s and Children’s Health 37 th Nursing
POGO, Saskatoon, Saskatchewan, March 24-25, 2011.
Immunization Initiatives to protect Our Kids. Women’s and Children’s Health 37th Nursing POGO, Saskatoon,
Saskatchewan, March 24-25, 2011.
HIV in pregnancy: making a difference. Women’s and Children’s Health 37th Nursing POGO, Saskatoon,
Saskatchewan, March 24-25, 2011.
Optimization of Prevention Programs: RSV. I Conferencia de Actualización en Pediatría – ALAPE 2011, Hotel Riu
Plaza, Panamá, April 7-10, 2011.
When antibiotics do not work: change in clinical practice in the era of increased antimicrobial resistance. I
Conferencia de Actualización en Pediatría – ALAPE 2011, Hotel Riu Plaza, Panamá, April 7-10, 2011.
Heinrich Feldmann
Emerging Zoonoses: preparedness and response. Department of Microbiology, University of Chicago, Chicago,
USA (2011).
Nonhuman primate models of influenza. NIAID 2011 Influenza Antiviral research Pipeline Wokshop. Bethesda,
MD. USA (2011).
Emerging zoonoses: preparedness and response. 1st International One Health Congress – Human Health, Animal
Health, the Environement and Global Survival. Melbourne Victoria, Australia (2011).
Zoonotic containment pathogens – identification, modeling, vaccines etc. Australian Animal Health Laboratory
(AAHL), CSIRO Livestock Industrie, Geelong, Australia (2011).
Viral hemorrhagic feves: emerging challenges for human and animal health. Animal health in the 21st Century. 3rd
International Symposium. Greifswald, Germany (2010).
Disease modeling of high containment pathogens. Rocky Moutnain Regional Center of Excellence for Biodefense
and Emerging Infectious Disease Research, annual meeting. Estes Park, USA (2010).
Emerging zoonotic viruses: response and preparedness. Sith World Conference on the Future of Science –
Viruses: the invisible enemy. Fondazione Giorgio Cini, Venice, Italy (2010).
BSL4 laboratories in North America. HEIBL Conference. Rome, Italy (2010).
Disease modeling of high containment pathogens. Center of Excellence for Emergeging and Zoonotic Animal
Diseases (CEEZAD). Symposium. Manhattan, Kansas, United States (2010).
Keith Fowke
“Immune Quiescence in the Nairobi Sex Worker Cohort” AIDS Vaccine 2010 Satellite Symposium, Atlanta,
Georgia, Sept 28, 2010.
“Immune Quiescence and Activation Kinetics in the Nairobi Sex Worker Cohort” Microbiology, Immunology and
Cancer Biology seminar series, University of Minnesota, Nov 1-2, 2010.
“Assessing influenza humoral responses with a soluble bead array assay”, 2nd Bioplex User Group meeting
Winnipeg, Nov, 10, 2010. Co-presented with Dr. Yoav Keynan.
“Exposed but not infected: The HIV resistant women from Kenya”. Frontiers of Biochemical Science Seminar
Series. University of Winnipeg, Nov 17, 2010.
“HIV Disease Progression in Manitoba” International HIV Prevention Exchange. Winnipeg, Canada, January 28,
2011
“HIV Disease Progression in Manitoba” National Microbiology Laboratory. Winnipeg, Canada, March 10, 2011
“The International Infectious Disease and Global Health Training Program: An example of Canada/Africa Training”
–African Educators Forum, Nigerians in Diaspora Organization (NIDO), Winnipeg, Canada, March 26, 2011.
Matthew Gilmour
2010. FDA National Antimicrobial Resistance Monitoring Systems (NARMS) Public Meeting. “Comparative Genomic
Fingerprinting of Campylobacter”. July 16th, 2010.
2010. Verotoxigenic E. coli Risk Identification and Risk Management Workshop. “Overview of public health
impacts of VTEC, their prevalence and implications for regulatory approaches (Canadian Perspective)”. November
1st, 2010
2010. Federal Food Safety and Nutrition Research Meeting 2010. “Overview of public health impacts of VTEC,
their prevalence and implications for regulatory approaches (Canadian Perspective).” November 3 rd, 2010.
2010. Federal Food Safety and Nutrition Research Meeting 2010. “Network of Networks (Plenary)”. November 3rd,
2010.
2010. Federal Food Safety and Nutrition Research Meeting 2010. “Molecular toolbox for VTEC characterization in
public health”. November 3rd, 2010.
2011. PHAC Science & Research Forum. Chair and presenter in the ‘Information Science’ Breakout session.
“Forging a Food Safety Network of Networks”. March 29th, 2011.
Morag Graham
2011.
Bacterial Genomics Working Group (NML). Winnipeg, MB, January 19, 2011: “Next-generation sequencing
platforms and its applications”.
2011
Public Health Agency of Canada’s 5th Annual Science and Research Forum. Gatineau, PQ, March 30, “The
ATCGs of public health response”.
2011
Department of Medical Microbiology, University of Manitoba. Winnipeg, MB, May 19, 2011: “Applications
of Genomics in Public Health”.
Gregory Hammond
“Forgotten but Not Gone: the Poliovirus”, at Bug Day, Health Sciences Centre, October 19, 2010 and also
presented at the University Women’s Club, April 27, 2011.
Daryl Hoban
July 31-August 1, 2010 – Invited Speaker, Merck Symposium, Taipei
Oct 1-3, 2010 – Invited Speaker, Abbott Symposium, Lebanon
Jan 7-9, 2011 – Invited Speaker, Forest Lab Advisory Board, Florida
March 24-25, 2011 – Invited Speaker, Abbott Advisory Board, Toronto
May 6, 2011 – Invited Speaker, Merck Symposium, Milan
May 17-18, 2011 – Invited Speaker, Abbott Advisory Board – Lithuania
June 17, 2011 – Invited Speaker, SMART Investigator’s Mtg – Montreal
Alan Jackson
Understanding and conquering human rabies: a glimpse back and a fresh look forward. Invited platform
presentation at the XXIst International Meeting on Research Advances and Rabies Control in the Americas in
Guadalajara, Mexico on October 19, 2010.
David Knox
Inventory Expansion and Appraisal of non-PrP Biomarkers of TSE Diseases. PrioNet/APRI Joint Annual Scientific
Meeting, Vancouver, BC, October 2010.
Plasma Proteome Changes in Mice Affected by Neurodegeneration. Prion 2010, Salzburg, Austria, September
2010.
Low Dose Radiation and Adaptation in Disease Progression. International Scientific Symposium, McMaster
University, Hamilton, Ontario. August 2010.
Gary Kobinger
2010. June 22-23 Filovirus Medical Countermeasures (MCM) Workshop – Gaithersburg Maryland USA
Title of talk: Biosafety Level (BSL)-4 Laboratory Capabilities and Capacities
2010. September 30-October 3 Dr. Eric Cohen Symposium. Title of talk: Influenza Infection in Ferrets and Ebola
infections in pigs.
2010. Oct 12-15 Milan - Annual International Symposium Biosecurity and Biosafety: Future trends and solutions.
Milan October 13-15, 2010. Title of Talk: Factors Influencing Disease Emergence.
2011. Jan 17-21 – Annual Scientific Review and Planning Meeting, University of Nairobi STD/AIDS Collaborative
Centre. Title of talk: The impact of infectious disease outbreak response on infectious control and vaccine
development.
2011. Mar 8 - Duke-NUS Graduate Medical School Singapore, 8 College Road, Khoo Teck Puat Building, Singapore
Title of Talk: The Emerging and Dangerous Pathogens Laboratory Network (EDPLN) to Optimise Outbreak
Response.
2011. June 16-19 – Public Security S & T Summer Symposium 2011 – Ottawa ON. Title of Talk: Pre-clinical
development of nasal adenovirus-based vaccine against Ebola virus.
Philippe Lagace-Wiens
July 7, 2010: Optimal use of microbiology Laboratory Resources: WRHA
October 29, 2010: Emerging and re-emerging diseases related to climate change: Community Health Sciences
November 19, 2010: Antibiotic Stewardship: International Collaborating Centre for Infectious Diseases
April 15, 2011: Jet lag: Manitoba Travel Health Network
April 15, 2011: Tropical dermatology: Manitoba Travel Health Network
June 2, 2011: Jet Lag: Department of Medicine Rounds, Saint-Boniface Hospital
June 8, 2011: Helminths – another neglected disease, University of Winnipeg Summer Institute in Infectious
Diseases
Linda Larcombe
University of Winnipeg, Global College Summer Institute in Infectious Disease III: Impact of Infectious Diseases
on Local and Global Investment and Development: June 8-12, 2009 – “No shelter from the storm: housing
conditions and health on northern First Nation Reserves”.
Northlands Denesuline First Nation, Lac Brochet Manitoba – Community meeting/feast and report on the status of
current studies (Vitamin D and macrophage function and (February 8, 2011).
Richard Lester
May 13, 2011 “Cell Phones: Evidence to Action for Improved Global HIV Outcomes”, Seminar at the World
Health Organization (WHO), Geneva, Switzerland.
May 17, 2011 “Can Cell Phone SMS (mHealth) Really Improve HIV Treatment Outcomes? Evidence for Scale-Up
from WelTel Kenya1” Special presentation at the United States government Office of the Global AIDS
Coordinator, Washington, DC.
May 18, 2011. Global Health Council panelist: Realizing the potential of mHealth- moving from pilots to
sustainable impact at scale. Washington, DC.
November 26, 2010. “STI Update”. St. Paul’s Hospital CME, Vancouver, BC.
September 18, 2010. “Strengthening Patient-Centred Care through Mobile Communications: An Example from
Kenya.” First Annual Symposium on Neglected Global Diseases (NGDI) at UBC.
Yan Li
Identification and monitoring the evolution of the 2009 pandemic H1N1: The Canadian Experience. The 8 th
National Clinical Microbiology and Immunology Conference, Shanghai, China (July 30-August 3, 2010).
Stephen Moses
Invited Speaker, Closing Plenary, 20th Annual Canadian Conference on HIV/AIDS Research, Toronto, Ontario,
Canada, April 14-17, 2011. “Male circumcision for HIV prevention: the intersection of science and
programming”.
Invited lecturer, University of Washington Department of Global Health, Implementation Science in Health course
(GH 590B), Seattle, Washington, USA, April 19, 2011. “Male circumcision for HIV prevention: science and
policy”.
Michael Mulvey
Invited Speaker. The Molecular Epidemiology of Clostridium difficile in Canada. December 3, 2010, University of
Manitoba.
Invited Speaker. Antimicrobial Resistance in Canada. Antibiotic Resistance: Past, Present, Future. May 15-18,
2011, Cold Spring Harbor, New York, USA.
Invited Speaker. The Northern Antibiotic Resistance Partnership. CIHR Café Scientifique. Antibiotics: How bacteria
are fighting back. May 24, 2011, Winnipeg, MB.
Invited Speaker. Antimicrobial Resistance Surveillance Activities in Canada. Laboratoire de santé publique du
Québec. June 22, 2011, Québec, QC.
Invited Speaker. The ever changing antimicrobial resistance landscape in Canada: Results from the Canadian
Integrated Program on Antibiotic Resistance Surveillance. Antimicrobial Resistance in animals and the
Environment. ARAE June 27, 2011, Tours, France.
Lindsay Nicolle
Invited Speaker & Moderator. “Urinary infection in older persons” in “Current Challenges in Urinary Tract
Infection”, 50th ICAAC, Boston, September 13, 2010.
Infectious Diseases Society of America, 48th Annual Meeting, Vancouver, October 2010. Moderator: Oral abstract
session: Bacterial Clinical Studies I. October 22, 2010. Invited Speaker: Meet the professor: Updates in UTI,
October 23, 2010.
Faculty 3rd AMIT Congress: Topics of Infectious and Tropical Diseases. “Prophylaxis and Treatment of Infections
in LTCFs: State of the art. Milan, March 11, 2011.
“Update in urinary tract infections”. Section of Urology weekly rounds, University of Manitoba, April 13, 2011.
Faculty “Update in management of urinary tract infections” Bannatyne Campus CPD for Family Physicians:
Urology, Winnipeg, April 15, 2011.
Control of antimicrobial resistance in Canada: any lesions to take? Worldwide HAI Forum, June 27 – 29, 2011,
Veyrier-du-Lac, France.
Control of antimicrobial resistance in Canada: any lesions to take? International Conference on Prevention and
Infection Control, June 29 – July 2, 2011 Geneva.
Pamela Orr
Presentation to Public Utilities Board, Province of Manitoba, “Determinants of Health in First Nations
Communities” with Dr. L. Larcombe , November 2-3, 2010.
“Housing and Health”. Presented at the “Building it Right” Manitoba Northern and Aboriginal Housing
Conference, Winnipeg, February 8-10, 2011.
“Agent, Host and Environment: How TB Research can inform our practice in Manitoba and Canada”. Presented
to Winnipeg Regional Health Authority TB meeting, March 24, 2011.
Rosanna Peeling
Jul 2010. “Diagnostic tools to monitor progress towards disease elimination”. WHO-LSHTM Consultation, London,
UK.
Jul 2010. “Malaria Diagnostics.” WHO TDR Disease Reference Group on Malaria, Maputo, Mozambique.
Sept 2010. “Improving Access, Quality and Affordability of Diagnostics through Technology Transfer and Local
Production” WHO First Forum on Medical Devices, Bangkok, Thailand.
Sept 2010. Development of diagnostics for drug resistant infections” ReAct Conference: The Global Need for
Effective Antibiotics: Moving towards Global Action, Upsala, Sweden.
Oct 2010. “Update on STI Diagnostics” WHO WPRO Midterm Review of the Regional Strategic Action Plan for
Prevention and Control of STIs, Ulaanbataar, Mongolia.
Oct 2010. “Point-of-care Diagnostics for Infectious Diseases: Promises and Challenges.” Molecular Diagnostics
Europe,, Hanover, Germany.
Oct 2010. “Malaria diagnostics” WHO TDR Disease Reference Group on Malaria Meeting, London, UK
Nov 2010. “Global Perspective on Point-of-care Diagnostics and their uptake, CIHR Knowledge Translation
Workshop, Montreal, Canada
Nov 2010. “Utility of New Diagnostic Tools for Dengue Management and Control”. American Society for Tropical
Medicine and Hygiene, Atlanta, USA.
Dec 2010. “Evaluation of Dengue Diagnostics. ”WHO TDR Dengue Evaluation Meeting, Ho Chi Min City, Vietnam.
Jan 2011. “Diagnostic Innovation to improve Global Health.” The 2nd Meeting of the China Network for Drugs and
Diagnostics Innovation, Shanghai, China.
May 2011. ”Rapid Tests for STIs.” DST and IUSTI meeting, Curitiba, Brazil.
June 2011. “Regulatory Issues in Diagnostics” Bill & Melinda Gates Foundation-Grand Challenges Canada meeting
on Point-of-care Diagnostics, Vancouver, Canada
Pierre Plourde
Havoc in Haiti – what is our role? (presentation to Winnipeg Chinese Christian Business & Professional
Association, Winnipeg) – October 1, 2010.
Welcome to Canada! Health Assessment for Refugees (presentation at Bug Day, Health Sciences Centre,
Winnipeg) – October 19, 2010.
Vaccines Update for Adults and Travelers (presentation at Infectious Diseases Update Conference – Global,
Tropical & Travel Medicine, Victoria, British Columbia) – November 12, 2010.
Risk Assessment of the Traveler in 2010 – Are You Current? (presentation at Infectious Diseases Update
Conference – Global, Tropical & Travel Medicine, Victoria, British Columbia) – November 12, 2010.
Global Medicine & Volunteerism: How to Prepare Yourself with Lessons Learned in Haiti (presentation at
Infectious Diseases Update Conference – Global, Tropical & Travel Medicine, Victoria, British Columbia) –
November 13, 2010.
TB Control – What does the Future hold? (presentation at Southern First Nations Tuberculosis Conference – “Past
Present and Future”, Brandon) – November 16, 2010.
CATMAT Update (Manitoba Travel Health Network Meeting, Winnipeg) – November 25, 2010.
Responding to Disasters: Immunizations for Healthcare and Other Aid Workers (presentation at 9th Canadian
Immunization Conference, Québec City) – December 6, 2010.
HIV and Disclosure Forum for HIV Care Providers (presentation for Nine Circles Community Health Centre,
Winnipeg) – January 10, 2011.
Prevalence and Trends of Sexually Transmitted and Blood Borne Infections in the Winnipeg Health Region
(presentation at the first annual WRHA STBBIs Conference, Winnipeg) – March 22, 2011.
TB Regional Services: Directions and New Roles (presentation at the second annual WRHA Regional Tuberculosis
Workshop, Winnipeg) – March 24, 2011.
Anatomy of a Community Outbreak (presentation at Mini Medical School program, Winnipeg) – April 20, 2011.
Medicine and Community Development in the Third World (workshop presentation at CMDS National Conference,
Winnipeg) – May 13, 2011.
Hamburger Disease (presentation to the Manitoba Kidney Foundation Annual General Meeting, Winnipeg) – May
18, 2011.
How to get Involved in International Healthcare Initiatives (presentation at Alberta Association of Travel Health
Professionals annual symposium, Canmore, Alberta) – June 17, 2011.
Hepatitis Prevention in Travellers (presentation at Alberta Association of Travel Health Professionals annual
symposium, Canmore, Alberta) – June 18, 2011.
Immunizations for Humanitarian & Disaster Relief Worker (presentation at Alberta Association of Travel Health
Professionals annual symposium, Canmore, Alberta) – June 18, 2011.
Frank Plummer
08/07/2010 Summary of the International Symposia on Natural Immunity to HIV (ISNIH) and the formation of an
International Natural Immunity Consortium (INIC) EU-HR Workshop at NIH Workshop at NIH Workshop on HIV Exposed and Resistant, Rockville, MD, USA.
23/09/2010 Presentation on his work U of M President's Luncheon, Winnipeg, Manitoba, Canada.
25/09/2010 Are we ready for the Next Pandemic Young President's Organization (YPO) Winnipeg, Manitoba,
Canada.
05/10/2010 Anticipating where the puck is going: Advanced technologies to combat infectious diseases
Canadian Hospital Business Development Network (CHBND) - Keynote Address, Winnipeg, Manitoba, Canada.
26/10/2010 The Role of Immune Quiesence in protecting against HIV infection: Lessons from a natural model of
resistance to infection by HIV 6th Annual Grand Challenges in Global Health Meeting, Seattle WA, USA.
08/12/2010 Presentation titled " Perspectives on Academic Research in Global Health in Canada - Canada's
Strategic Role in Global Health Canadian Academy of Health Sciences (CAHS) - Expert Witness and participate in
a Roundtable, Ottawa, Ontario, Canada.
17/01/2011 Presentation Annual Scientific Review and Planning Meeting, University of Nairobi STD/AIDS
Collaborative Centre, Nairobi, Kenya.
28/01/2011 Immune Quiescence in HIV Resistant Sex Workers HIV Symposium - HIV Resistant Sex Workers
Informing Vaccine Design, Winnipeg, Manitoba, Canada Invited Speaker.
15/02/2011 15-minute presentation TEDxManitoba Event, Winnipeg, Manitoba, Canada Invited Speaker.
29/03/2011 What is Public Health doing and what are our scientific and program delivery priorities?
Phac Forum, Ottawa, Ontario, Canada.
31/03/2011 Presentation Michael G DeGroote Institute for Infectious Disease Research SAB Meeting 2011,
Niagara-On-The-lake, Ontario, Canada - Invited Speaker.
12/04/2011 Presentation on PHAC - The Microbiology Laboratory, how it works. Centre for the Advancement of
Health Innovations (CAHI) Conferenc, Winnipeg, Manitoba, Canada Invited Speaker.
20/04/2011 PHAC Mobile Lab -how its been used in the past to help our international partners Speaker e Learn
for SPD in Ottawa, Ontario, Canada Invited Speaker.
26/04/2011 Presentation HIV Research Symposium, Winnipeg, Manitoba, Canada Invited Speaker.
04/05/2011 Presentation - PHAC Science and Research Strategic Plan.
Allan Ronald
HIV Dementia. Annual Nairobi Retreat, January 19, 2011.
Update in Hepatitis C and Lessons Learned from 30 Years with HIV. Annual Internal Medicine Meeting,
Vancouver Island Internists, Tofina, B.C., June 4-5, 2011.
Laura Saward
Presentation to Manitoba Institute of Children’s Health titled “Learning from the success of maternal passive
immunization strategies to protect the neonate” November 4, 2010.
Frank Schweizer
Novel approaches to antimirobial chemotherapy inspired by the antimicrobial peptide scaffold. University of
Ottawa, January 27, 2011.
Novel approaches to antimicrobial chemotherapy. Western Canadian Medicinal Chemistry Workshop, Saskatoon,
September 24-26, 2010.
Novel Approaches to antimicrobial chemotherapy and new insights into structural glycobiology. Tokai University,
Japan, August 07, 2010.
Stabilization of the polyproline II helix by hydroxyproline glycosylation. International Carbohydrate Symposium at
Makehari Messe, Tokyo. August 01-06, 2010.
Design, synthesis and antibacterial properties of novel antibacterial scaffolds. Noguchi Institute, Itabashi-ku,
Tokyo, July 30, 2010.
Novel approaches to antibacterial chemotherapy inspired by the antimicrobial peptide scaffold. Keio University,
Department of Chemistry, Tokyo, July 29, 2010.
Design, Synthesis and antibacterial properties of antibacterial peptidomimetics. Shibaura Institute of Technology,
Department of Chemistry, Tokyo, July 28, 2010.
Alberto Severini
“Herpesvirus in animals – focus on monkeys and apes” Nobel meets Darwin Symposium – The evolution of
infectious agents in relation to sex. Karlskoga, Sweden, October 21-23, 2010.
Stuart Skinner
March 24, 2011 “HIV in Pregnancy: Making a Difference,” Women’s and Children’s Health Conference,
Saskatoon, SK.
May 18th, 2011 “HIV and Pregnancy.” Saskatchewan Prevention Institute. Meadow Lake, SK.
May 14th, 2011 Update on Sexually Transmitted Infections with Oral manifestations in Saskatchewan. The
College of Dental Surgeons of Saskatchewan: Continuing Dental Education. Saskatoon, Sask.
May 14th, 2011 HIV in Saskatchewan and the Implication for Dentistry. The College of Dental Surgeons of
Saskatchewan: Continuing Dental Education. Saskatoon, Sask.
March 28th, 2011 “Overview of HIV in Pregnancy.” Meeting of Saskatoon Tribal Council Community Nurses.
Saskatoon, Sask.
March 16th, 2011 “HIV/AIDS and Pregnancy”. La Ronge Health Center.
October 27th, 2010 “HIV in Saskatoon: An Update.” Regina QuAppelle Health Region. Wascana Rehabilitation
Center, Regina, Sask.
Marylou Solbrig
Causes of Acute Encephalitis. Annual STD-HIV Conference Nairobi Jan 2011.
Elijah Songok
March 17th 2011: Division of Medical Virology, University of Stellenbosch, Cape Town, South Africa. Workshop on
Cryopreservation of biological material for biological and Immunological Assays in HIV Vaccine related research.
James Strong
Medical Management of Filovirus Infections. Presented to the IDSA 48 th Annual Meeting, Vancouver B.C.
Jude Uzonna
Vaccines and vaccination for parasitic diseases: myth, mirage or reality? Department of Parasitology, Faculty of
Veterinary Medicine, University of Nigeria. August 3, 2011.
Regulation of secondary anti-Leishmania immunity by the phosphoinositide 3 kinase. International Congress of
Parasitology, Melbourne, August 17, 2010.
Finding a vaccine for a deadly parasitic disease. Frontiers of Biochemical Science Seminar Series, University of
Winnipeg November 10, 2010.
Persistent parasites and anti-Leishmania immunity: implications for vaccine designs and vaccination strategies.
Department of Microbiology and Immunology Guest Speaker Series, McGill University. October 21, 2010 and
Department of Pharmacology, University of Manitoba May, 2010.
Genetically modified live-attenuated parasites as alternative vaccine candidates for effective vaccination against
cutaneous leishmaniasis. Guest speaker, International Primate Research Center, Nairobi, Kenya, October 14,
2010.
Paul Van Caeseele
An Update on Newborn Screening in Manitoba: Past, Present and Future. Pediatric Grand Rounds, Faculty of
Medicine, University of Manitoba, Winnipeg, Manitoba, February 24, 2011.
Gary Van Domselaar
Applied Bioinformatics & Public Health Microbiology Meeting Summary, June 1-3, 2011 Bacterial Genomics
Working Group Meeting, NML, July 04, 2011.
Quasispecies Assembly with QAssembler Med Micro Seminar Series, Faculty of Medical Microbiology, University of
Manitoba, May12, 2011.
Scientific Computing and Government Policy at the Public Health Agency of Canada Public Health Agency of
Canada Research Forum, Gatineau, Quebec, Mar 30, 2011.
"Next Generation Sequencing Applications in Public Health", Presentation to BC CDC, Vancouver, BCOct 14, 2010.
“Next Generation Sequencing Applications in Public Health", Presentation to University of Victoria Faculty of
Microbiology and Biochemistry Oct 15, 2010.
Hana Weingartl
9th IVIS, Tokyo, Japan, August 15-20, 2010: “Role of immune response in pathogenesis of Nipah virus in swine”.
Interagency RVFV Working Group meeting, Manhattan, Kansas, December 7-8, 2010: “CFIA Research Progress,
Rift Valley fever”.
University of Saskatchewan Robert and Virginia Rausch Visiting Professorship Award, March 2011: “Pathogenesis
on Nipah virus in swine”, and “Emergence of zoonotic viruses – the pig connection”.
John Wylie
Sexual networks and transmission dynamics of chlamydia and gonorrhea. The Canadian Public Health Laboratory
Network Semi Annual General Meeting. April 26, 2011, Winnipeg, MB (National).
Heterogeneity and infectious diseases: Social network analysis in Manitoba and new opportunities in Colombia.
International HIV Prevention Exchange. Winnipeg, MB, January 28-29, 2011. (international).
Xi Yang
Invited Speaker: My CIHR supported research. Institute Advisory Board meeting of the institute of infection and
immunity of CIHR. Winnipeg, May 2011.
Invited Speaker: Cell interaction in infection. China-Canada Scientific Forum. Zhangjiakow, June 2011.
Invited Speaker and co-chair: Dirty is healthier, how can that happen? International symposium on advanced
medicine. Tianjin, June 2011.
Invited Speaker and session Chair: NKT as adjuvant?-the Chlamydia story. World Congress on Vaccine 2011.
Beijing, April 2011.
Xiao-Jian Yao
Identification of a Novel Anti-HIV Molecule and Characterization of the Mode of Its Action. The 8th Annual
Congress of International Drug Discovery Science and Technology. Beijing, China, Oct 25, 2010.
Investigation of HIV/host protein interactions required fo HIV replication and search for new anti-HIV approach.
Tianjin Medical University. Tianjin, Oct 27, 2010.
Development of a new “intracellular Immuniczation” strategy to restrict HIV-1 infection and induce host immune
response. International HIV Prevention Exchange Symposium. Fort Gary Hotel. Winnipeg, Canada, Jan 28-29,
2011.
Better understanding of how HIV escapes from various host defense systems: Molecular basis for new anti-HIV
strategies. Advances of mucosal HIV immunology and beyond: HIV Research Symposium. Apotex Centre, 750
McDermot Ave, Winnipeg, Canada, April 26, 2011.
Molecular mechanisms of how HIV-1 manipulates host cell machinery to enable their replication and escape from
the host defense. Life Science Institute, Central South University, Hunan, China, May 30, 2011.
George Zhanel
“Evolving face of antimicrobial resistance.” Presented at the symposium Zero Tolerance for Hospital Acquired
Infections, Florida Society of Health System Pharmacists (FSHP), Orlando, Florida, July 30, 2010.
“The role of carbapenems in the treatment of intraabdominal infections.” Presented at surgery/infectious diseases
symposium on treatment of intraabdominal infections, Toronto, Ontario, September 24, 2010.
“Antibiotic discovery and development: Solutions to infections caused by resistant organisms.” Presented at
chemistry grand rounds, University of Winnipeg, Winnipeg, Manitoba, October 1, 2010.
“Treatment of antimicrobial resistant infections in the US: Focus on resistant Gram-positive cocci and multi-drug
resistant (MDR) Gram-negative bacilli”, Presented at the Missouri Society of Managed Care System Pharmacists,
St. Louis, Missouri, October 14, 2010.
“Hospital–associated infections: Problems and solutions“. Presented at the North Carolina Society of Pharmacists,
Durham, North Carolina, October 25, 2010.
“Treatment of surgical intraabdominal infections: The new Canadian guidelines“. Presented at a surgery/internal
medicine update, Brandon, Manitoba, October 28, 2010.
“Comparison of carbapenems to other antimicrobial classes: What’s the data ?“. Presented at an infectious
diseases national update, Quebec City, Quebec, November 6, 2010.
“What pathogens are causing infections in your ICU ?“. Presented at the Canadian Critical care Forum, Toronto,
Ontario, November 8, 2010.
“Antimicrobial considerations for preventing and treating infectious diseases“. Presented at a Family Physician
Update, Toronto, Ontario, November 20, 2010.
“Clostridium difficile: Introduction” Presented at Clostridium difficile associated disease (CDAD) symposium,
Winnipeg, Manitoba, December 7, 2010.
“Epidemiology, microbiology, prevention and treatment of surgical intraabdominal infections“. Presented at a
surgery grand rounds, Winnipeg, Manitoba, January 19, 2011.
“What antimicrobials lead to optimal bacteriological and clinical outcomes in the treatment of surgical
intraabdominal infections and complicated skin and skin structure infections“. Presented to the Manitoba branch
of the Canadian Society of Hospital Pharmacy (CSHP), Winnipeg, Manitoba, January 19, 2011.
“Comparison of carbapenems: Current and investigational agents. Comparisons to the penicillins and
cephalosporins“. Presented to the drug use evaluation professional specialties group, University of Toronto,
Toronto, Ontario, January 20, 2011.
“A comparison of the macrolides azithromycin, clarithromycin and erythromycin: What about Zmax SR ?“.
Presented at a specialist meeting, Toronto, Ontario, February 5, 2011.
“Review of the recommendations for the prevention and treatment of surgical intraabdominal infections“.
Presented at surgery rounds, Winnipeg, Manitoba, February 28, 2011.
“General attributes that employers look for when hiring graduate students“. Presented at Breaking into the
Manitoba job market, Winnipeg, Manitoba, March 7, 2011.
“Infections caused by antimicrobial resistant superbugs in community practice: What does it mean ? “ Presented
at Family Physician Update, Vancouver, British Columbia, March 19, 2011.
“Antibiotics, vaccines and probiotics: Keys to treating and preventions infections“. Presented at a Specialist
Physician Update, Calgary, Manitoba, April 16, 2011.
“The lipoglycopeptides: Comparison of dalbavancin, oritavancin and telavancin to the glycopeptide vancomycin“.
Presented at a Specialist Update, New Jersey, NewYork, April 27, 2011.